tiprankstipranks
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesMadrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
21d ago
Madrigal Pharmaceuticals price target raised to $405 from $325 at Evercore ISI
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $405 from $325 at Evercore ISI
1M ago
Madrigal Pharmaceuticals 750K share Spot Secondary priced at $260.00
PremiumThe Fly
Madrigal Pharmaceuticals 750K share Spot Secondary priced at $260.00
1M ago
BofA says 89bio should trade with strength after ‘win for entire MASH space’
PremiumThe FlyBofA says 89bio should trade with strength after ‘win for entire MASH space’
1M ago
Madrigal Stock Rises on FDA Approval
PremiumMarket News
Madrigal Stock Rises on FDA Approval
1M ago
DoorDash upgraded, GM initiated: Wall Street’s top analyst calls
PremiumThe Fly
DoorDash upgraded, GM initiated: Wall Street’s top analyst calls
1M ago
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
PremiumThe FlyApproval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
1M ago
Madrigal Pharmaceuticals price target raised to $377 from $338 at Canaccord
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $377 from $338 at Canaccord
1M ago
Viking Therapeutics price target raised to $100 from $86 at BTIG
PremiumThe Fly
Viking Therapeutics price target raised to $100 from $86 at BTIG
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100